Table 3.
Cox proportional hazards | |||
---|---|---|---|
aHR | 95% CI | p value | |
EDA-3 | |||
|
Ref. | – | – |
|
1.4 | 0.7-2.8 | 0.3 |
|
2.2 | 1.2-4.1 | 0.01 |
|
3.3 | 1.8-6.1 | <0.001 |
|
Ref. | – | - |
|
1.4 | 0.8-2.3 | 0.2 |
|
3.6 | 2.2-6 | <0.001 |
|
4.9 | 3.1-7.8 | <0.001 |
|
Ref. | – | – |
|
2.1 | 1.2-3.6 | 0.008 |
|
1.8 | 0.9-3.3 | 0.06 |
|
2.8 | 1.6-4.7 | <0.001 |
EDSS≥3 | |||
|
Ref. | – | – |
|
2.3 | 1.2-4.3 | 0.01 |
|
1.8 | 0.9-3.3 | 0.06 |
|
4.6 | 2.6-8.2 | <0.001 |
|
Ref. | – | – |
|
1.7 | 1.04-2.8 | 0.035 |
|
0.7 | 0.4-1.5 | 0.4 |
|
2 | 1.5-5.1 | <0.001 |
|
Ref. | – | – |
|
1.7 | 0.9-3.1 | 0.12 |
|
1.2 | 0.6-2.4 | 0.7 |
|
3.3 | 1.7-6.4 | <0.001 |
EDSS≥6 | |||
|
Ref. | – | – |
|
5.7 | 1.5-22.7 | 0.01 |
|
3.7 | 1-13.8 | 0.05 |
|
8.2 | 2.3-30 | <0.001 |
|
Ref. | – | – |
|
2.4 | 0.9-6.2 | 0.06 |
|
0.8 | 0.2-2.9 | 0.8 |
|
3.4 | 1.05-10.9 | 0.04 |
|
Ref. | – | – |
|
1.97 | 0.6-6.5 | 0.26 |
|
2 | 0.53-7.6 | 0.31 |
|
7.4 | 2.3-24.4 | <0.001 |
aHR, adjusted hazard ratio; CI, confidence interval; EDA, Evidence of Disease Activity; cNFL, cerebrospinal fluid neurofilament light; Ig, immunoglobulin; IF, intrathecal fraction; EDSS, expanded disability status scale; OCMB, oligoclonal IgM bands. Multivariable analysis assessing the additive predictive value of cNFL and IgM-index regarding EDA-3 status at 24 months after the first relapse, EDSS≥3, and EDSS≥6. Bold p values indicate statistical significance (p<0.05).